About
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company's product portfolio includes prescription products in various therapeutic areas, such as oncology, diabetes, gastro-intestinal care, nephrology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, Mpox, and hepatitis A vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Key Metrics
as of Sep 2026Market Cap2,333 Cr
P/E—
Div Yield0.00 %
Book Value₹136.00
52w High₹648.00
52w Low₹292.00
Face Value₹1.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 199.57 | 166.75 | 165.19 | 141.13 | 166.70 | 132.53 | 163.49 | 147.35 | 115.72 | 136.46 | 150.50 | 143.02 | 129.19 |
| Expenses | 193.90 | 164.18 | 153.45 | 158.92 | 167.88 | 159.41 | 155.53 | 140.35 | 129.71 | 142.50 | 150.65 | 146.58 | 139.50 |
| Operating Profit | 5.67 | 2.57 | 11.74 | -17.79 | -1.18 | -26.88 | 7.96 | 7.00 | -13.99 | -6.04 | -0.15 | -3.56 | -10.31 |
| OPM % | 2.84 | 1.54 | 7.11 | -12.61 | -0.71 | -20.28 | 4.87 | 4.75 | -12.09 | -4.43 | -0.10 | -2.49 | -7.98 |
| Other Income | 6.98 | 5.26 | 5.05 | 9.10 | 16.99 | 36.30 | 6.39 | 7.42 | 6.54 | 13.55 | 8.46 | 6.00 | 33.82 |
| Depreciation | 7.90 | 7.88 | 8.45 | 8.34 | 8.39 | 8.42 | 8.98 | 8.68 | 8.73 | 8.81 | 9.11 | 9.31 | 9.48 |
| Interest | 1.18 | 1.20 | 1.85 | 2.14 | 0.86 | 1.04 | 0.99 | 0.98 | 0.87 | 0.82 | 0.85 | 0.91 | 1.00 |
| Profit before tax | 3.57 | -1.25 | 6.49 | -19.17 | 6.56 | -0.04 | 4.38 | 4.76 | -17.05 | -2.12 | -1.65 | -7.78 | 13.03 |
| Tax % | 38.38 | -20.00 | 40.06 | -26.92 | 39.63 | 4,875.00 | -1.37 | 1.05 | -6.86 | -6.13 | 33.33 | 6.56 | 15.73 |
| Net Profit | 2.20 | -1.00 | 3.89 | -14.01 | 3.96 | -1.99 | 4.44 | 4.71 | -15.88 | -1.99 | -2.20 | -8.29 | 10.98 |
| EPS in Rs | 0.38 | 0.08 | 0.65 | -2.27 | 0.66 | -0.31 | 0.74 | 0.78 | -2.58 | -0.32 | -0.37 | -1.35 | 1.79 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 640.00 | 559.00 | 559.00 | 460.00 | 661.00 | 625.00 | 544.00 | 457.00 | 593.00 | 544.00 | 653.00 | 687.00 |
| Expenses | 644.00 | 584.00 | 579.00 | 558.00 | 674.00 | 548.00 | 484.00 | 591.00 | 509.00 | 505.00 | 541.00 | 643.00 |
| Operating Profit | -5.00 | -25.00 | -20.00 | -98.00 | -13.00 | 77.00 | 60.00 | -134.00 | 84.00 | 39.00 | 112.00 | 44.00 |
| OPM % | -0.70 | -4.40 | -3.50 | -21.00 | -2.00 | 12.00 | 11.00 | -29.00 | 14.00 | 7.00 | 17.00 | 6.00 |
| Other Income | 36.00 | 55.00 | 62.00 | 154.00 | 1,687.00 | 9.00 | -21.00 | 338.00 | 8.00 | 62.00 | 70.00 | 28.00 |
| Interest | 6.00 | 4.00 | 4.00 | 4.00 | 181.00 | 185.00 | 174.00 | 105.00 | 101.00 | 101.00 | 127.00 | 105.00 |
| Depreciation | 33.00 | 35.00 | 37.00 | 39.00 | 44.00 | 46.00 | 43.00 | 54.00 | 57.00 | 68.00 | 73.00 | 67.00 |
| Profit before tax | -7.00 | -8.00 | 1.00 | 13.00 | 1,449.00 | -146.00 | -178.00 | 45.00 | -66.00 | -67.00 | -19.00 | -99.00 |
| Tax % | -3.00 | 10.00 | 201.00 | 363.00 | 26.00 | 1.00 | 9.00 | 17.00 | 15.00 | -16.00 | 10.00 | 3.00 |
| Net Profit | -7.00 | -9.00 | -2.00 | -34.00 | 1,078.00 | -148.00 | -194.00 | 38.00 | -76.00 | -56.00 | -21.00 | -108.00 |
| EPS in Rs | -0.88 | -1.37 | -0.19 | -5.42 | 175.91 | -24.09 | -31.69 | 6.15 | -12.07 | -8.89 | -2.98 | -17.38 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
| Reserves | 829.00 | 829.00 | 836.00 | 837.00 | 871.00 | -235.00 | 193.00 | 344.00 | 303.00 | 350.00 | 426.00 | 449.00 |
| Borrowings | 24.00 | 22.00 | 21.00 | 20.00 | 34.00 | 820.00 | 742.00 | 646.00 | 941.00 | 994.00 | 1,105.00 | 1,111.00 |
| Other Liabilities | 404.00 | 433.00 | 378.00 | 407.00 | 848.00 | 587.00 | 449.00 | 379.00 | 349.00 | 440.00 | 317.00 | 364.00 |
| Total Liabilities | 1,262.00 | 1,290.00 | 1,241.00 | 1,271.00 | 1,759.00 | 1,178.00 | 1,390.00 | 1,376.00 | 1,598.00 | 1,789.00 | 1,854.00 | 1,930.00 |
| Fixed Assets | 620.00 | 567.00 | 582.00 | 600.00 | 622.00 | 609.00 | 657.00 | 806.00 | 949.00 | 1,001.00 | 1,071.00 | 1,144.00 |
| CWIP | 100.00 | 128.00 | 102.00 | 42.00 | 17.00 | 34.00 | 24.00 | 23.00 | 40.00 | 30.00 | 161.00 | 155.00 |
| Investments | 10.00 | 3.00 | 40.00 | 13.00 | 5.00 | 0.00 | 6.00 | 5.00 | 7.00 | 7.00 | 9.00 | 15.00 |
| Other Assets | 532.00 | 592.00 | 517.00 | 615.00 | 1,114.00 | 534.00 | 703.00 | 542.00 | 602.00 | 750.00 | 614.00 | 616.00 |
| Total Assets | 1,262.00 | 1,290.00 | 1,241.00 | 1,271.00 | 1,759.00 | 1,178.00 | 1,390.00 | 1,376.00 | 1,598.00 | 1,789.00 | 1,854.00 | 1,930.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 17.00 | -27.00 | 0.00 | -422.00 | -108.00 | 107.00 | -30.00 | 105.00 | 118.00 | 131.00 | 91.00 | 37.00 |
| Cash from Investing Activity | -40.00 | 65.00 | 10.00 | 430.00 | 1,283.00 | -48.00 | -35.00 | -6.00 | 55.00 | -26.00 | 16.00 | -37.00 |
| Cash from Financing Activity | -1.00 | -3.00 | -3.00 | -18.00 | -1,176.00 | -47.00 | 91.00 | -101.00 | -164.00 | -107.00 | -117.00 | -1.00 |
| Net Cash Flow | -25.00 | 35.00 | 7.00 | -10.00 | -2.00 | 12.00 | 26.00 | -2.00 | 9.00 | -2.00 | -10.00 | -1.00 |
| Free Cash Flow | -37.00 | -77.00 | -71.00 | -424.00 | -119.00 | 89.00 | -21.00 | 100.00 | 103.00 | 107.00 | 85.00 | 30.00 |
| CFO/OP % | -496.00 | 108.00 | -12.00 | 429.00 | -2,235.00 | 141.00 | -36.00 | -77.00 | 146.00 | 320.00 | 64.00 | 96.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 42.00 | 47.00 | 37.00 | 48.00 | 45.00 | 49.00 | 46.00 | 71.00 | 84.00 | 95.00 | 79.00 | 52.00 |
| Inventory Days | 251.00 | 391.00 | 282.00 | 292.00 | 296.00 | 311.00 | 344.00 | 173.00 | 651.00 | 770.00 | 516.00 | 404.00 |
| Days Payable | 247.00 | 413.00 | 244.00 | 256.00 | 327.00 | 440.00 | 463.00 | 572.00 | 540.00 | 607.00 | 318.00 | 272.00 |
| Cash Conversion Cycle | 46.00 | 25.00 | 76.00 | 83.00 | 14.00 | -80.00 | -73.00 | -328.00 | 195.00 | 259.00 | 278.00 | 184.00 |
| Working Capital Days | 57.00 | 44.00 | -2.00 | -5.00 | -229.00 | -43.00 | 93.00 | -363.00 | -96.00 | -46.00 | 27.00 | -126.00 |
| ROCE % | -2.00 | -5.00 | -4.00 | -10.00 | -6.00 | 5.00 | 5.00 | -16.00 | 3.00 | 2.00 | 4.00 | 0.00 |
Corporate Actions
23 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Other | 19 Sep 2024 | — | — | — | Annual General Meeting |
| Other | 21 Sep 2023 | — | — | — | Annual General Meeting |
| Other | 19 Sep 2022 | — | — | — | Annual General Meeting |
| Other | 16 Sep 2021 | — | — | — | Annual General Meeting |
| Other | 15 Dec 2020 | — | — | — | Annual General Meeting |
| Other | 21 Sep 2020 | 22 Sep 2020 | — | — | Spin Off |
| Other | 21 Sep 2020 | 22 Sep 2020 | — | — | Demerger |
| Other | 19 Sep 2019 | — | — | — | Annual General Meeting |
| Other | 19 Sep 2018 | — | — | — | Annual General Meeting |
| Other | 18 Sep 2017 | — | — | — | Annual General Meeting |
| Other | 22 Sep 2016 | — | — | — | Annual General Meeting |
| Other | 22 Sep 2015 | — | — | — | Annual General Meeting |
| Other | 17 Sep 2014 | — | — | — | Annual General Meeting |
| Other | 17 Sep 2013 | — | — | — | Annual General Meeting |
| Other | 20 Sep 2012 | — | — | — | Annual General Meeting |
| Dividend | 19 Sep 2011 | — | — | 0.75 | |
| Dividend | 16 Sep 2010 | — | — | 0.25 | |
| Other | 18 Sep 2009 | — | — | — | Annual General Meeting |
| Dividend | 19 Sep 2008 | — | — | 1.00 | |
| Dividend | 21 Sep 2007 | — | — | 1.00 | |
| Dividend | 22 Sep 2006 | — | — | 1.00 | |
| Other | 12 Aug 2005 | — | — | — | Agm/Dividend @ 150% |
| Dividend | 07 Aug 2001 | — | — | 10.00 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update30 Dec 2019 from care
-
Rating update30 Dec 2019 from care
-
Rating update8 Feb 2019 from care
-
Rating update7 Dec 2017 from care
-
Rating update26 Sep 2017 from care
-
Rating update20 Sep 2017 from care